M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma
Clinical trial NCT00477906 · UNKNOWN
Trial details
- NCT number
- NCT00477906
- Sponsor
- AVAX Technologies
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2019-01-01
- Enrollment
- 387
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.